| Column |
Title |
Type |
Description |
| ODS_CODE |
Organisation Data Service code for pharmacy, appliance, or local pharmaceutical services contractor |
string |
The Organisation Data Service (ODS) code of the premises at which pharmaceutical services may be provided
|
| PHARMACY_NAME |
Trading name of contractor |
string |
The name under which a pharmacy contractor, appliance contractor, or local pharmaceutical services contractor trades
|
| ICB_NAME |
Integrated Care Board (ICB) Name |
string |
The name under which a pharmacy contractor, appliance contractor, or local pharmaceutical services contractor trades
|
| ICB_CODE |
Integrated Care Board (ICB) Code |
string |
The unique code used to refer to an ICB
|
| Q1 |
A question asked whilst completing the quality domain in the PQS declaration on MYS |
string |
Do you declare that by the end of 31 March 2023 you will have completed the TARGET treating your infections review? Answers: yes / no Mandatory
|
| Q2 |
A question asked whilst completing the quality domain in the PQS declaration on MYS |
string |
Do you declare that where concerns are identified when completing the TARGET treating your infections review, the patient's GP will be promptly notified? Answers: yes / no Mandatory
|
| Q3 |
A question asked whilst completing the quality domain in the PQS declaration on MYS |
string |
Do you declare that by the end of 31 March 2023 you will have shared your anonymised audit data or declared that no patients have been identified as being suitable for review via the data collection tool on the NHSBSA MYS application? Answers: yes / no Mandatory
|
| Q4 |
A question asked whilst completing the quality domain in the PQS declaration on MYS |
string |
Between 1 April 2020 and the end of 31 March 2023, will all non-registered pharmacy staff working at the pharmacy on the day of the declaration have satisfactorily completed the infection prevention and control Level 1 e-learning and assessment on the e-Learning for Healthcare website? Answers: yes / no Mandatory
|
| Q5 |
A question asked whilst completing the quality domain in the PQS declaration on MYS |
string |
Between 1 April 2020 and the end of 31 March 2023, will all registered pharmacy professionals working at the pharmacy on the day of the declaration have satisfactorily completed the HEE infection prevention and control Level 2 e-learning and assessment? Answers: yes / no Mandatory
|
| Q6 |
A question asked whilst completing the quality domain in the PQS declaration on MYS |
string |
Between 1 April 2020 and the end of 31 March 2023, will all patient-facing pharmacy staff working at the pharmacy on the day of declaration have satisfactorily completed the Antimicrobial Stewardship for Community Pharmacy e-learning and e-assessment? Answers: yes / no Mandatory
|
| Q7 |
A question asked whilst completing the quality domain in the PQS declaration on MYS |
string |
By the end of 31 March 2023, will all patient-facing staff working at the pharmacy on the day of the declaration and who provide health advice have become Antibiotic Guardians and have an awareness of the local antibiotic formulary? Answers: yes / no Mandatory
|
| Q8 |
A question asked whilst completing the quality domain in the PQS declaration on MYS |
string |
By the end of 31 March 2023, do you declare that you will have, at premises level, a new or updated AMS action plan on how you would promote AMS in your day-to-day practice, which will be available for inspection on the premises? Answers: yes / no Mandatory
|
| Q9 |
A question asked whilst completing the quality domain in the PQS declaration on MYS |
string |
By the end of 31 March 2023, will all patient-facing staff working at the pharmacy on the day of declaration, who provide advice on medicines or healthcare, have completed Module 1 of the Let''s Communicate Cancer (BOPA) and completed the associated quiz which is available on the elfh website, or have completed the BOPA Let''s Communicate Cancer Series on the BOPA website since 31 March 2021 and have the certificate of completion? Answers: yes / no Mandatory
|
| Q10 |
A question asked whilst completing the quality domain in the PQS declaration on MYS |
string |
Do you declare that, by the end of 31 March 2023, the pharmacy will have available, at premises level, a new risk review undertaken as part of the PQS 2022/23 which includes the management plans to minimise the risk of missing suspected cancer symptoms? Answers: yes / no Mandatory
|
| Q11 |
A question asked whilst completing the quality domain in the PQS declaration on MYS |
string |
Can you evidence that you have a process in place to identify red flag signs and symptoms that could be suspected cancer symptoms and refer these patients to their GP? Answers: yes / no Mandatory
|
| Q12 |
A question asked whilst completing the quality domain in the PQS declaration on MYS |
integer |
By the day of declaration, how many patients were referred to their GP following detection of red flag signs and symptoms that could be suspected cancer symptoms? Answers: 0 - 100 (capped at 100) Mandatory
|